Optimizing Complement Inhibition for Paroxysmal Nocturnal Hemoglobinuria: A Focus on Novel Therapies and Managed Care Opportunity

Optimizing Complement Inhibition for Paroxysmal Nocturnal Hemoglobinuria: A Focus on Novel Therapies and Managed Care Opportunity

Describe the pathogenesis, diagnosis, and burden of PNH 
Assess the latest clinical data related to the treatment of PNH, with particular focus on the limitations of traditional therapies and the promise of newer/novel complement inhibitors
Implement evidence-based and cost-effective managed care policies that incorporate novel complement inhibitor therapies for the personalized care of patients with PNH

  • Provider:HMP Education
  • Activity Link: https://hmpeducation.com/program/2023-mcln-201-1
  • Start Date: 2023-03-29 05:00:00
  • End Date: 2023-03-29 05:00:00
  • Credit Details: IPCE Credits: 1.0 hours
    AAPA Category 1 Credit™️: 1.0 hours
    AMA PRA Category 1 Credit™️: 1.0 hours
    Nursing: 1.0 hours
    Pharmacy: 1.0 hours
  • MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
  • Commercial Support: Source: Apellis - Amount: 150000.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: General Surgery
«
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.